1. Home
  2. MEIP vs KIRK Comparison

MEIP vs KIRK Comparison

Compare MEIP & KIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MEIP
  • KIRK
  • Stock Information
  • Founded
  • MEIP 2000
  • KIRK 1966
  • Country
  • MEIP United States
  • KIRK United States
  • Employees
  • MEIP N/A
  • KIRK N/A
  • Industry
  • MEIP Biotechnology: Pharmaceutical Preparations
  • KIRK Diversified Commercial Services
  • Sector
  • MEIP Health Care
  • KIRK Miscellaneous
  • Exchange
  • MEIP Nasdaq
  • KIRK Nasdaq
  • Market Cap
  • MEIP 17.1M
  • KIRK 20.2M
  • IPO Year
  • MEIP 2003
  • KIRK 2002
  • Fundamental
  • Price
  • MEIP $1.98
  • KIRK $1.23
  • Analyst Decision
  • MEIP Hold
  • KIRK Buy
  • Analyst Count
  • MEIP 1
  • KIRK 2
  • Target Price
  • MEIP N/A
  • KIRK $4.50
  • AVG Volume (30 Days)
  • MEIP 11.6K
  • KIRK 101.2K
  • Earning Date
  • MEIP 05-08-2025
  • KIRK 06-05-2025
  • Dividend Yield
  • MEIP N/A
  • KIRK N/A
  • EPS Growth
  • MEIP N/A
  • KIRK N/A
  • EPS
  • MEIP N/A
  • KIRK N/A
  • Revenue
  • MEIP N/A
  • KIRK $458,411,000.00
  • Revenue This Year
  • MEIP N/A
  • KIRK N/A
  • Revenue Next Year
  • MEIP N/A
  • KIRK $0.37
  • P/E Ratio
  • MEIP N/A
  • KIRK N/A
  • Revenue Growth
  • MEIP 33.76
  • KIRK N/A
  • 52 Week Low
  • MEIP $1.46
  • KIRK $1.10
  • 52 Week High
  • MEIP $4.10
  • KIRK $2.57
  • Technical
  • Relative Strength Index (RSI)
  • MEIP 40.20
  • KIRK 48.49
  • Support Level
  • MEIP $1.86
  • KIRK $1.13
  • Resistance Level
  • MEIP $2.35
  • KIRK $1.22
  • Average True Range (ATR)
  • MEIP 0.16
  • KIRK 0.08
  • MACD
  • MEIP 0.02
  • KIRK 0.01
  • Stochastic Oscillator
  • MEIP 68.42
  • KIRK 57.50

About MEIP MEI Pharma Inc.

MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer and Pracinostat, an oral histone deacetylase inhibitor. Geographically, all the business activities function through the region of the United States.

About KIRK Kirkland's Inc. COMMONSTOCK

Kirkland's Inc is a specialty retailer of home decor and gifts in the United States. The company stores provide various merchandise, including holiday decor, value pricing, and a stimulating in-store and online environment that provides customers with a brand experience. The company stores also offer an assortment of holiday merchandise in seasonal periods, as well as items that are suitable for gift-giving.

Share on Social Networks: